Combination of Fat-Free Muscle Index and Total Spontaneous Portosystemic Shunt Area Identifies High-Risk Cirrhosis Patients
暂无分享,去创建一个
C. Strassburg | A. Faron | J. Rockstroh | J. Trebicka | A. Sprinkart | J. Luetkens | C. Jansen | M. Praktiknjo | Johannes Chang | N. Böhling | A. Luu | J. Abu-Omar | U. Attenberger | A. M. Luu
[1] R. Moreau,et al. Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation , 2020, Gut.
[2] R. Moreau,et al. Cardiodynamic state is associated with systemic inflammation and fatal acute‐on‐chronic liver failure , 2020, Liver international : official journal of the International Association for the Study of the Liver.
[3] R. Fimmers,et al. Yttrium-90 radioembolization for hepatocellular carcinoma: Outcome prediction with MRI derived fat-free muscle area. , 2020, European journal of radiology.
[4] C. Strassburg,et al. Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis. , 2020, Journal of hepatology.
[5] A. Montano‐Loza,et al. Sarcopenia in Cirrhosis: Looking Beyond the Skeletal Muscle Loss to See the Systemic Disease , 2019, Hepatology.
[6] A. Farcomeni,et al. Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis , 2019, Hepatology.
[7] R. Butterworth. L-Ornithine L-Aspartate for the Treatment of Sarcopenia in Chronic Liver Disease: The Taming of a Vicious Cycle , 2019, Canadian journal of gastroenterology & hepatology.
[8] C. Strassburg,et al. Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt , 2019, Clinical and translational gastroenterology.
[9] A. Faron,et al. Quantification of fat and skeletal muscle tissue at abdominal computed tomography: associations between single-slice measurements and total compartment volumes , 2019, Abdominal Radiology.
[10] R. Fimmers,et al. Fat-free muscle area measured by magnetic resonance imaging predicts overall survival of patients undergoing radioembolization of colorectal cancer liver metastases , 2019, European Radiology.
[11] M. Plauth,et al. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. , 2019, Journal of hepatology.
[12] D. Fan,et al. Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosis. , 2018, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[13] T. Berg,et al. Loss of paraspinal muscle mass is a gender‐specific consequence of cirrhosis that predicts complications and death , 2018, Alimentary pharmacology & therapeutics.
[14] C. Rose,et al. Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis , 2018, Hepatology International.
[15] D. Toth,et al. Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis. , 2018, Gastroenterology.
[16] C. Strassburg,et al. Fat‐free muscle mass in magnetic resonance imaging predicts acute‐on‐chronic liver failure and survival in decompensated cirrhosis , 2018, Hepatology.
[17] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.
[18] S. Baik,et al. Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis , 2017, PloS one.
[19] Shan Hai,et al. Sarcopenia as a predictor of all-cause mortality among community-dwelling older people: A systematic review and meta-analysis. , 2017, Maturitas.
[20] J. Bosch,et al. Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The SportDiet study , 2017, Hepatology.
[21] D. Samuel,et al. A new definition of sarcopenia in patients with cirrhosis undergoing liver transplantation , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[22] Manuela Merli,et al. Sarcopenia from mechanism to diagnosis and treatment in liver disease. , 2016, Journal of hepatology.
[23] M. Dunn,et al. Muscle at Risk: The Multiple Impacts of Ammonia on Sarcopenia and Frailty in Cirrhosis , 2016, Clinical and Translational Gastroenterology.
[24] P. Angus,et al. Review article: sarcopenia in cirrhosis – aetiology, implications and potential therapeutic interventions , 2016, Alimentary pharmacology & therapeutics.
[25] Shu-Fang Chang,et al. Systematic Literature Review and Meta-Analysis of the Association of Sarcopenia With Mortality. , 2016, Worldviews on evidence-based nursing.
[26] J. Mezhir,et al. The impact of sarcopenia on survival and complications in surgical oncology: A review of the current literature , 2015, Journal of surgical oncology.
[27] M. Sawyer,et al. Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis , 2015, Clinical and Translational Gastroenterology.
[28] J. Talwalkar,et al. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases. , 2014, Journal of hepatology.
[29] V. Vilgrain,et al. Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography. , 2014, Journal of hepatology.
[30] A. Burroughs,et al. Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: A multicenter survey on safety and efficacy , 2013, Hepatology.
[31] A. McCullough,et al. Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stent , 2013, European journal of gastroenterology & hepatology.
[32] M. Sawyer,et al. Muscle wasting is associated with mortality in patients with cirrhosis. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[33] Michael L Volk,et al. Hospital Readmissions Among Patients With Decompensated Cirrhosis , 2012, The American Journal of Gastroenterology.
[34] Review of current literature , 1993, International Urogynecology Journal.